Life Sciences & Healthcare
Our Life Sciences & Healthcare team is experienced in advising on such developments.
SKW Schwarz is not only versed in the interface between medicine and IT, however, but also has many years of experience in other growth areas, such as venture capital, private equity, capital increases, and mergers & acquisitions. Our clients, whether they are start-up entrepreneurs or pharmaceutical corporations, rely on our proven expertise.
This also applies to the regulatory issues governing such issues as product liability, distribution law, IP, and the advertisement of pharmaceutical products. We maintain a long-standing collaboration with the relevant industry associations.
In order to link our expertise with international networks, we joined Biolegis. Biolegis brings together 120 life science lawyers from 20 countries, which makes it the largest network of its kind in Europe.
This gives our clients access to the local expertise as well as reliable collaboration afforded by our partner firms.
The use of cannabis products in medicine is expected to increase in the German health market after several therapies have benefited from the approval of medical cannabis. As demand increases, so does the number of suppliers of cannabis products. Medical cannabis use is associated with a number of legal and regulatory issues, which producers, distributors, and users should bear in mind.learn more